VC23

VC23 is an investment management company that focuses on early-stage companies and management teams with breakthrough technologies. It finds, analyzes, and structures venture capital investments in companies. They concentrate on biotechnology but also have an interest in other technology fields. They are versatile and collaborative and will lead capital rounds or join existing rounds as a smaller participant. Whenever possible, they seek to co-invest with other VC firms or early-stage investors. The company was founded in 2007 and headquartered in Avon, Connecticut.

3 past transactions

Codetta Bio

Series A in 2022
Codetta Bio is a life sciences company working on a novel multi-omic analysis platform based on digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsIPCR) (dsiPCR). Its integrated reagent, hardware, and software platform enable multiplexed, multi-omic liquid biopsy and isolated DNA, RNA, and protein analyses. The company aims to provide the life sciences community with a simultaneous multi-omic dsPCR solution that will accelerate research and development of next-generation therapies, improving patient care and quality of life.

Fluent BioSciences

Series A in 2020
Fluent Biosciences is a life science "single cell" technology company that offers molecular analysis of cells without the use of complex microfluidic instrumentation. The company’s proprietary platform, Pre-Templated Instant Partitions (PIPseqTM), provides instantaneous self-assembly of individual cells or molecules into millions of uniform partitions for sensitive, unbiased preparation of proteins and nucleic acids for sequencing applications. Fluent's technology expands accessibility of single cell, molecule, or protein analysis to every laboratory, enabling broader market access across all researchers in biotech, pharma, and academic centers.

Tangen Biosciences

Series A in 2019
Tangen Biosciences is a biotechnology company that offers molecular diagnostic technology services. It develops medical instruments that provide rapid nucleic acid detection with the specificity and sensitivity of polymerase chain reaction (PCR) amplification.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.